5. 進行性核上性麻痺 Progressive supranuclear palsy Clinical trials / Disease details

臨床試験数 : 89 / 薬物数 : 107 - (DrugBank : 40) / 標的遺伝子数 : 65 - 標的パスウェイ数 : 108

1 trial found

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00211224 (ClinicalTrials.gov)	April 2000	13/9/2005	Neuroprotection and Natural History in Parkinson's Plus Syndromes (NNIPPS)	Phase 3 Study of Riluzolein Multiple System Atrophy (MSA) and Progressive Supranuclear Palsy (PSP) ( ...	Multiple System Atrophy;Progressive Supranuclear Palsy	Drug: Riluzole	King's College London	Assistance Publique - Hôpitaux de Paris;University of Ulm;Aventis Pharmaceuticals	Terminated	30 Years	80 Years	Both	800	Phase 3	United Kingdom

First Previous1Next Last